| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.7 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |